Mark Cone - 15 Nov 2022 Form 4/A - Amendment Insider Report for biote Corp. (BTMD)

Role: Director
Signature: /s/ Marybeth Conlon, as Attorney-in-Fact for Mark Cone
Issuer symbol: BTMD
Transactions as of: 15 Nov 2022
Transactions value $: $0
Form type: 4/A - Amendment
Filing time: 18 Nov 2022, 15:02:52 UTC
Date Of Original Report: 16 Nov 2022
Previous filing: 13 Dec 2022
Next filing: 04 Jan 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BTMD	Stock Option (Right to Buy)	Award	$0	+31.7K		$0.00	31.7K	15 Nov 2022	Class A Common Stock	31.7K	$3.97	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	All shares subject to the option award shall vest on the earlier of May 26, 2023 or the day prior to the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.

Remarks:

This Amendment to the original Form 4 filed on November 16, 2022 (the "Original Form 4") is being filed solely to correct the exercise price in Column 2 of Table II. All other information in the Original Form 4 remains the same.